Home » Topics » BioWorld Science

BioWorld Science
RSS

Lexipafant for pancreatitis

March 15, 1996

Zadaxin effective in HBV patients

March 15, 1996

Calixarene derivatives from University of Alabama

March 15, 1996

Dosmalfate pending Spanish approval

March 15, 1996

Teikoku Hormone claims antiulcer drugs

March 15, 1996

Takeda targets Helicobacter pylori

March 15, 1996

Anti-Helicobacter agents from Janssen

March 15, 1996

Synsorb develops drug for hemorrhagic colitis

March 15, 1996

VML-252 for hyperphosphatemia

March 15, 1996

Fibrinogen antagonists from E. Merck

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...